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In metazoans, factors of the insulin family control
growth, metabolism, longevity, and fertility in re-
sponse to environmental cues. InDrosophila, a family
of seven insulin-like peptides, called Dilps, activate a
common insulin receptor. Some Dilp peptides carry
both metabolic and growth functions, raising the
possibility that various binding partners specify their
functions. Here we identify dALS, the fly ortholog of
the vertebrate insulin-like growth factor (IGF)-binding
protein acid-labile subunit (ALS), as a Dilp partner
that forms a circulating trimeric complex with one
molecule of Dilp and one molecule of Imp-L2, an
IgG-family molecule distantly related to mammalian
IGF-binding proteins (IGFBPs). We further show
that dALS antagonizes Dilp function to control animal
growth as well as carbohydrate and fat metabolism.
These results lead us to propose an evolutionary per-
spective in which ALS function appeared prior to the
separation between metabolic and growth effects
that are associated with vertebrate insulin and IGFs.
INTRODUCTION
Members of the insulin-like peptide (ILP) family are found in a
wide range of metazoans, where they control carbohydrate
metabolism, tissue growth, reproduction, and longevity. The
functional separation between insulin-like growth factor (IGF)
and insulin signaling, as seen in mammals, dates back 600 mil-
lion years, as the two types of molecules are already present
in the lower metazoan tunicate phylum (Sherwood et al., 2006).
Insulin and IGF-1 carry different biological functions, in part
through their binding to closely related receptors, the insulin
receptor (IR) and the IGF-1 receptor (IGF-1R), respectively. In
contrast to insulin, which is produced and stored in specific en-
docrine tissues and is released by a highly regulated process,
vertebrate IGF-1 accumulates in body fluids, where it associates
with a large array of binding molecules globally referred to as
IGF-binding proteins (IGFBPs). These play important thoughcryptic functions in controlling the biological activity of IGF-1
(Rosenfeld et al., 2000; Duan and Xu, 2005). Vertebrates have
six bona fide IGFBPs, which directly bind IGF-1 and form stable
binary complexes in the circulating blood. These binary com-
plexes comprise 10% of the total plasma IGF-1. Most of the re-
maining plasma IGF-1 is bound up into ternary complexes com-
prising one molecule of IGFBP-3 or IGFBP-5 and one molecule
of acid-labile subunit (ALS), leaving only 1% of plasma IGF-1
free (Boisclair et al., 2001). The binding of IGF partners greatly
enhances the half-life of IGF-1 but also restrains its ability to in-
teract with its receptor, IGF-1R, leading to the formation of a large
reservoir of circulating IGF-1. The ALS partner is essential for the
stabilization of circulating IGF-1, as deficiencies in the ALS gene
in both mouse and human lead to a drastic reduction in plasma
levels of IGF-1 and IGFBP-3 (Domene et al., 2005, 2007). Ternary
IGF-1 complexes have been proposed to contribute to the func-
tional separation between IGF-1 and insulin by preventing illegit-
imate interaction between high blood concentrations of IGF-1
and the insulin receptor. While in vivo studies of IGFBP and ALS
in mammals have revealed some key functions of these mole-
cules in controlling the physiology of IGF-1, a full understanding
of how these regulations take place in complex organisms is still
lacking (Duan and Xu, 2005; Domene et al., 2005).
Insects provide a simpler evolutionary alternative, possessing
a single insulin-like system that represents a possible ancestor of
the dual insulin/IGF system (Wu and Brown, 2006). InDrosophila,
seven insulin-like peptide (Dilp)-encoding genes have been iden-
tified. These interact genetically with a unique insulin receptor
called dInR. The dilp genes are expressed in different larval tis-
sues, suggesting that they carry specific functions. At least three
of them (dilp2, 3, and 5) are expressed in two symmetric clusters
of seven neurosecretory cells called the insulin-producing cells
(IPCs), located in each brain hemisphere. Ablation of these neu-
rons leads to dramatically smaller body size with increased levels
of circulating carbohydrate (trehalose in insects) in the hemo-
lymph, indicating that the Dilp peptides produced in brain IPCs
control both carbohydrate homeostasis and tissue growth (Bro-
giolo et al., 2001; Rulifson et al., 2002). Interestingly, growth and
trehalose level defects are rescued by ectopic expression of one
Dilp, Dilp2, suggesting that at least this molecule carries both
metabolic and growth functions (Rulifson et al., 2002). However,
individual genetic analysis of dilp genes, which should yieldCell Metabolism 7, 333–338, April 2008 ª2008 Elsevier Inc. 333
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not yet been performed.
In the current study, we tested the possibility that specific
complexes between the Dilps and binding partners may restrict
their interactions with dInR, thereby specifying their functions.
Both a putative ALS ortholog (dALS; Colombani et al., 2003)
and a possible candidate for an ILP-binding protein (encoded
by the Imaginal morphogenesis protein-Late 2 [Imp-L2] gene;
Garbe et al., 1993) have been identified in Drosophila. The
Imp-L2 protein is a member of the immunoglobulin superfamily,
which shares slight homology with the mammalian IGF-binding
protein-related protein 1 (IGFBP-rP1/IGFBP-7; Yamanaka et al.,
1997). It can bind human IGF-1 in vitro (Sloth Andersen et al.,
2000) and functions as a growth inhibitor in Drosophila (B.H.,
H. Stocker, and E. Hafen, unpublished data). We now present
evidence that Dilp2 forms a trimeric complex with the Drosophila
ALS and Imp-L2 proteins. We further demonstrate that dALS is
required for the growth and metabolic functions of the Dilps.
This indicates that the formation of a trimeric complex containing
dALS and some Dilp peptides is a prerequisite for both metabolic
and growth control in flies.
RESULTS
We previously identified CG8561 as a candidate gene encoding
a putative Drosophila ortholog of the vertebrate ALS protein,
which we called dALS (Colombani et al., 2003). The dALS protein
contains a series of 21 leucine-rich repeats (LRRs) that also form
the core of the vertebrate ALS. Based on sequence similarity and
the presence of LRRs, two additional related sequences were
found in the Drosophila genome (see Table S1 available online).
We examined the expression levels of all three genes in larval
tissues and in normally fed or starved animals. We had previously
established that CG8561 is exclusively expressed in two larval
tissues that play important roles in growth and metabolic regula-
tion: the 14 IPCs in the brain, and the fat body (FB), a larval tissue
that shares some functions with the vertebrate liver and fat
(Colombani et al., 2003). Remarkably, dALS expression in the
FB is suppressed under amino acid restriction (as determined
by qPCR on ppl>SlifA larvae; see below), a finding reminiscent
of the strong downregulation of the vertebrate ALS gene ob-
served in the liver under starvation (Colombani et al., 2003).
The two other related genes did not show clear expression in
any of the larval tissues, nor did they show nutrition-regulated
expression. We therefore focused our analysis on CG8561
(Table S1).
dALS, Dilp2, and Imp-L2 Are Found in a Common
Protein Complex
We first addressed whether dALS is able to form stable com-
plexes with Drosophila insulin-like peptides. In mammals, IGF-1
binds to a variety of IGFBPs, which serve as adaptor molecules
for the binding of ALS and the formation of a stable trimeric com-
plex. Therefore, we hypothesized that Imp-L2, a possible Dro-
sophila ILP-binding protein (Garbe et al., 1993; Sloth Andersen
et al., 2000), might be required for the interaction between Dilps
and dALS. To test this possibility, S2 cells were transfected with
various combinations of tagged Dilp2-, dALS-, and Imp-L2-
expressing constructs. dALS-myc (dALSM) was immunoprecipi-334 Cell Metabolism 7, 333–338, April 2008 ª2008 Elsevier Inc.tated from cell lysates, and the immunoprecipitates were tested
for the presence of Dilp2 and/or Imp-L2 by western blotting. We
observed that dALS and Imp-L2 physically interact in the ab-
sence of Dilp2 but that dALS and Dilp2 do not interact directly.
However, coexpressing Imp-L2 together with dALS and Dilp2
allowed coprecipitation of Dilp2 with dALS (Figure 1A). These
results indicate that the three proteins form a trimeric protein
complex and that Imp-L2 serves as a molecular bridge between
Dilp2 and dALS. Dilp2 and Imp-L2 did not coprecipitate in con-
trol experiments in which dALS was replaced with the unrelated
protein eIF4E, indicating that the interaction is specific for dALS
(Figure 1B). Interactions between Dilp3 and Dilp5, two other
Dilps expressed in the IPCs, and dALS were also tested using
the same experimental protocol. A specific coprecipitation of
dALS and Dilp5 was observed in the absence of Imp-L2. Inter-
estingly, the coexpression of Imp-L2 suppressed the interaction,
suggesting that dALS and Dilp5 interact through a distinct Dilp-
binding protein (Dilp-BP) present in S2 cells that is outcompeted
by Imp-L2 for binding to dALS (Figure 1C). Under the same con-
ditions, no interaction was observed between dALS, Dilp3, and
Imp-L2 (data not shown).
The physical interaction between dALS and Dilp2 was further
confirmed in vivo. Expression of the tagged protein dALSM in the
FB leads to its accumulation in vesicular structures suggestive of
the secretory pathway (Figure 2A), as well as in the larval hemo-
lymph, indicating that it behaves like a lymph-circulating se-
creted protein (Figure 2B). We tested the presence of circulating
complexes containing dALS and Dilp2 in coprecipitation exper-
iments using larval hemolymph. The presence of Dilp2 in the
dALS immunoprecipitate and, conversely, the presence of
dALS in the Dilp2 immunoprecipitate were indeed revealed by
western blotting (Figure 2C). Therefore, dALS can form circulat-
ing complexes with several Dilps and Dilp-BPs, including the
product of the Imp-L2 gene.
dALS Is Required for Proper Growth Regulation
To analyze the role of dALS in the control of Dilp function in
greater detail, we investigated the effects of tissue-specific
loss or gain of function of dALS on larval growth and metabolism.
For this purpose, we utilized UAS-driven lines allowing Gal4-
induced tissue-specific expression of normal (dALS) or myc-
tagged (dALSM) dALS protein, as well as dALS RNAi (dALSi) to
silence dALS expression. Gal4 lines that either partially or totally
recapitulate the expression pattern of the dALS gene were used:
pumpless-Gal4 (ppl-Gal4), which expresses Gal4 in the larval FB,
dilp2-Gal4, which expresses Gal4 specifically in the brain IPCs,
and a recombinant line that expresses Gal4 in both tissues. Ex-
pressing a dALSi construct with ppl-Gal4 lowered the total larval
dALS mRNA level by 45% (Figure 3A). Interestingly, altered
dALS expression levels in the FB of growing larvae led to
changes in adult size: dALS overexpression reduced adult
male mass by 14%, whereas dALS silencing increased the
mass by 12% (Figure 3B). Under these conditions, no delay in
larval development was observed, but the larval growth rate
was accelerated in RNAi-expressing lines and reduced in
dALS-expressing lines (Figure 3C).
Fat body cells can be efficiently used to produce and secrete
large amounts of proteins in the hemolymph. To functionally test
the interaction between dALS and Dilps in vivo, we used ectopic
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with dALS in the FB. Although Dilp2 is normally not expressed
in FB cells, ectopic expression of Dilp2F in this tissue leads to
a systemic increase in adult mass, suggesting that these cells
are capable of producing and secreting functional Dilp2F
(Figure 3B; see also Supplemental Experimental Procedures). In-
terestingly, coexpression of dALS and Dilp2F in FB cells signifi-
cantly reduced the adult mass increase observed upon Dilp2F
expression alone, indicating that dALS counteracts the effect
of Dilp2 on the control of animal growth (Figure 3B). Neither over-
expressing nor silencing dALS in the brain IPCs had any effect on
growth (Figure S1A). In accordance with these results, dALS or
dALSi expression in both the FB and the IPCs resulted in growth
phenotypes indistinguishable from FB expression alone (data
not shown). Together, these data suggest that dALS acts as
a negative regulator of the larval growth rate by counteracting
Dilp function and that dALS function is required in the FB. No
Figure 1. Physical Interaction between dALS and Dilp2 In Vitro and
In Vivo
(A) Coimmunoprecipitation of dALS, Imp-L2, and Dilp2 proteins from totalDro-
sophila S2 cell extracts. Myc-tagged dALS was precipitated following single,
double, or triple transfections, and the immunoprecipitates were analyzed
by western blotting (WB) with anti-FLAG (Dilp2F), anti-Myc (dALSM), or anti-
HA (Imp-L2HA) antibodies.
(B) Absence of coimmunoprecipitation of Dilp2 with a control protein (deIF4E).
Myc-tagged deIF4E was precipitated following single, double, or triple trans-
fections, and the immunoprecipitates were analyzed by WB with anti-FLAG
(Dilp2F) or anti-Myc (deIF4EM) antibodies.
(C) Coimmunoprecipitation of dALS and Dilp5 from total Drosophila S2 cells
extracts. Myc-tagged dALS was precipitated following single, double, or triple
transfections, and the immunoprecipitates were analyzed by WB with anti-
FLAG (Dilp5F) or anti-Myc (dALSM) antibodies. Black arrowhead indicates
the FLAG-Dilp5 band.clear function associated with dALS expression in the IPCs could
be identified by our analysis.
dALS Is Required for Proper Regulation
of Energy Homeostasis
Our experiments also revealed that dALS antagonizes the func-
tion of fly Dilps in the control of carbohydrate and fat metabo-
lism. The disaccharide trehalose is the main circulating carbo-
hydrate in the insect hemolymph. The control of trehalose
levels by the Dilps and the glucagon-like adipokinetic hormone
(AKH) shows striking parallels to the control of glycemia in ver-
tebrates (Broughton et al., 2005; Kim and Rulifson, 2004; Rulif-
son et al., 2002). In measuring total trehalose in larval hemo-
lymph, we observed a 25% increase in animals expressing
dALS in the FB and a 21% reduction in animals with FB-specific
dALS silencing (Figure 4A). Additionally, FB-specific expression
of dALS reduced larval di- and triacylglycerol (DAG+TAG) levels,
Figure 2. dALS Is a Secreted Protein that Interacts with Circulating
Dilp2
(A) When overexpressed in the fat body with the ppl-Gal4 driver (ppl>), myc-
tagged dALS (dALSM) appears in small punctate structures in the cytoplasm
of fat cells that are characteristic of vesicular structures.
(B) The dALSM protein produced in the fat body is found in the larval hemo-
lymph. Immunoprecipitates and western blotting of dALSM protein from the
hemolymph of ppl>dALSM larvae are shown. Black arrowhead, dALSM; white
arrowhead, background bands.
(C) Coimmunoprecipitation of dALS and Dilp2 from third-instar larval hemo-
lymph extracts. dALSM without or with FLAG-tagged Dilp2 (Dilp2F) was ex-
pressed in the larval fat body using the ppl-Gal4 driver. Tagged proteins
were immunoprecipitated from larval hemolymph, and the precipitates were
analyzed by western blotting (WB) to detect either dALSM or Dilp2F (black ar-
rowhead). Mouse anti-Myc IgG light chains revealed by anti-mouse secondary
antibodies are indicated by white arrowhead.Cell Metabolism 7, 333–338, April 2008 ª2008 Elsevier Inc. 335
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DAG+TAG (Figure 4B). Dilp2F expression in the FB strongly re-
duced circulating trehalose levels and increased total fat con-
Figure 3. dALS Is a Secreted Protein that Controls Growth
Nonautonomously
For all experiments, the ppl-Gal4 driver was used to direct expression in the
larval fat body.
(A) Measurements of larval dALS transcripts by quantitative RT-PCR. dALS
overexpression (dALS) and silencing (dALSi) conditions are shown relative to
control (all crosses at 29C, except ppl>SlifA at 25C). Fold changes (f.c.)
are indicated, and Act-5C is used as an internal reference. dALSi does not
modify transcription of two closely related genes (CG5195 and CG7896),
and no clear off-targets were detected using computer analysis, validating
this construct for dALS loss of function. ppl>SlifA larvae present limited amino
acid import in their fat body, mimicking a state of food deprivation (Colombani
et al., 2003).
(B) Adult weight measurements in conditions of modified dALS expression.
Varying dALS expression in the larval fat body modifies growth: dALS overex-
pression (dALS and dALSM) decreases adult mass, whereas dALS silencing
(dALSi) increases it. The mass increase induced by dilp2F expression is par-
tially rescued by dALSM expression. (29C; n = 30; **p < 0.01; bracket indicates
genotypes compared for p value calculation.)
(C) Measurement of larval growth rate in arbitrary units (a.u.). Changes in larval
weight are detectable as early as 72 hr after egg laying and increase through-
out larval development. (29C; n = 5 3 30; *p < 0.05, **p < 0.01.)
Error bars represent SEM.336 Cell Metabolism 7, 333–338, April 2008 ª2008 Elsevier Inc.tent (Figures 4A and 4B). As was seen in the case of growth reg-
ulation, coexpression of dALS with Dilp2F almost completely
suppressed the metabolic changes observed upon Dilp2F ex-
pression alone, suggesting an antagonistic genetic interaction
between dilp2 and dALS in metabolic regulation (Figures 4A
and 4B).
The effects of dALS on metabolic control were confirmed us-
ing a readout for lipid mobilization. Upon starvation, a portion of
Figure 4. dALS Is Required for Metabolic Regulation and Becomes
Limiting for Growth upon Nutritional Stress
For all experiments, the ppl-Gal4 driver was used to direct expression in the
larval fat body.
(A) Measurements of trehalose levels in the larval hemolymph. Trehalose levels
were measured after conversion of hemolymph trehalose into glucose. dALS
overexpression (dALS and dALSM) increases trehalosemia, whereas dALS si-
lencing (dALSi) decreases it. Moreover, coexpression of dALSM with dilp2F
rescues the hypotrehalosemia induced by dilp2F expression alone. (25C;
**p < 0.01.)
(B) Measurements of total triacylglycerol (TAG) in larvae. Increased dALS ex-
pression (dALS and dALSM) leads to a reduction in larval TAG, whereas
dALS silencing (dALSi) increases it. dALS expression fully rescues the TAG in-
crease induced by dilp2F expression alone. (25C; **p < 0.01.) TAG levels are
normalized to total protein levels.
(C) Lipid accumulation in oenocytes of fed and starved larvae from different ge-
notypes shown using oil red O staining.
(D) Weight measurements of animals with modified dALS expression levels
raised on yeast-deprived (0.13) medium (starved). Under conditions of nutri-
tional stress, dALS overexpression (dALS and dALSM) increases adult mass,
whereas dALS silencing (dALSi) decreases it. (29C; n = 2 3 30; *p < 0.05,
**p < 0.01.)
Error bars represent SEM.
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called oenocytes (Gutierrez et al., 2007). This accumulation is
easily detected using oil red O staining and serves as a sensitive
indicator of lipid mobilization in fat cells. In normally fed animals,
fat staining in oenocytes was barely detectable (Figure 4C). In
animals subjected to 8 hr fasting on PBS/1% sucrose medium,
a dramatic accumulation of fat droplets was observed in oeno-
cytes, while nearby muscles and ectodermal cells remained un-
stained (Figure 4C; Gutierrez et al., 2007). Interestingly, dALS
expression in fed larvae (ppl>dALS) triggered oenocyte lipid
accumulation, thereby mimicking the effects of starvation,
whereas dALS silencing (ppl>dALSi) had no visible effect
(Figure 4C). This extends our previous observations and sug-
gests that increased dALS expression generally inhibits insu-
lin/IGF signaling (IIS), leading to the mobilization and release
of lipid stores from fat cells, followed by their uptake into
oenocytes.
Overall, this series of experiments demonstrates that dALS not
only regulates growth rate but also antagonizes circulating Dilps
in the control of energy metabolism.
dALS Function Becomes Limiting
for Growth upon Nutritional Stress
Our previous experiments (Colombani et al., 2003) indicated that
dALS expression in the FB varies with the nutritional status of
the larva, suggesting that dALS might participate in the regula-
tion of IIS in response to variations in nutritional conditions.
We therefore tested the requirement for dALS function under
limited nutrient conditions. Strikingly, manipulating dALS ex-
pression in the FB yielded opposite results in fed and starved an-
imals. In particular, FB-specific dALS expression (ppl>dALS) did
not increase lipid staining in oenocytes of starved larvae, while
dALS silencing (ppl>dALSi) did (Figure 4C), indicating that
dALS function is required to limit the extent of lipid remobiliza-
tion during starvation.
We next measured the effect of varying dALS expression on
the size of animals raised under limited nutrient conditions. For
this purpose, larvae were raised on agar medium containing
only 10% of the normal yeast content (1.7 g/l), a condition
that significantly reduces adult size. Under these conditions,
increased dALS expression partially compensated for the size
defect, whereas dALS silencing further inhibited growth and
decreased viability (Figure 4D). These results are again in con-
trast with the dALS-induced growth inhibition observed under
normal food conditions and suggest that, although dALS coun-
teracts Dilp function in normally fed animals, it becomes limit-
ing for proper IIS activation under conditions of nutritional
stress.
DISCUSSION
This work presents the functional characterization of an insulin/
IGF binding partner in invertebrates and provides strong evi-
dence for the formation of a trimeric complex involving Dilp2,
dALS, and Imp-L2, a molecule with Dilp-binding protein function
in Drosophila. No binding was observed between dALS and
Dilp2 in the absence of Imp-L2, suggesting that, as with the tri-
meric IGF-1 complexes circulating in mammalian blood, the
binding of dALS requires prior formation of a dimeric Dilp/Imp-L2 complex. Dilp5, another member of the ILP family in Dro-
sophila, is also capable of forming a complex with dALS in
cultured cells. Interestingly, the binding of Dilp5 and dALS is
suppressed by excess Imp-L2, suggesting that one or more
other Dilp-BPs produced in S2 cells compete with dALS binding
for the formation of Dilp5 complexes. We propose that dALS
may function as a common scaffold protein for different Dilp/
Dilp-BP complexes in the hemolymph, with specific Dilp-BPs
participating in the specialization of Dilp functions. At present,
the technical difficulty of measuring the levels of endogenous
Dilps in the hemolymph ofDrosophila larvae precludes a detailed
analysis of the types and amounts of circulating Dilp/Dilp-BP/
dALS complexes.
No abnormal phenotypes were observed upon dALS overex-
pression or silencing in the brain IPCs. This could be due to
a lack of sensitivity in our method, as we found that expressing
dALSM in the 14 IPCs leads to very low accumulation of dALSM
in the hemolymph as compared to its expression in the FB (data
not shown). Conversely, silencing dALS in the IPCs does not re-
duce global dALS transcript levels, possibly because an impor-
tant dALS transcription from FB cells is masking this effect. We
also noticed that, when expressed in the IPCs, dALSM is not
present in the same vesicular structures as Dilp2 (Figure S1C),
suggesting that the two molecules are not found in a preassem-
bled complex before being released into the hemolymph. Deter-
mination of the function of IPC-produced dALS will require
further examination.
Our results point to a dual effect of dALS in the control of IIS
that depends on nutritional status. We interpret this dual effect
in light of the complex functions of IGFBPs and ALS in mam-
mals. Under optimal nutritional conditions, Dilps are not limiting,
and overexpression of dALS can induce the recruitment of more
Dilps into stable but inactive trimeric complexes. If the release
of active Dilp molecules is limited by the amounts of the various
proteases that break apart the trimeric complexes, the net ef-
fect of dALS overexpression will be growth inhibition, as ob-
served in vivo. In contrast, fasting leads to a general inhibition
of IIS that may reveal a positive function for dALS: Dilp mole-
cules becoming limiting, and dALS overexpression may in-
crease the half-life of circulating Dilps and thereby enhance
Dilp signaling (as long as the proteases are not limiting). Along
these lines, the severe downregulation of dALS transcription
observed under limited nutrient conditions (Colombani et al.,
2003; Figure 3A) suggests that dALS participates in the adapta-
tion of IIS to limited nutrition and the necessity of slowing down
growth rate as well as carbohydrate and fat metabolism. Alter-
natively, the opposing results observed in starved versus fed
conditions could be explained by the differential regulation of
Dilp/dALS complexes involved in distinct regulations of IIS in
response to nutritional conditions.
It has been proposed that in vertebrates, the formation of tri-
meric IGF/IGFBP/ALS complexes contributes to the functional
separation between insulin and IGFs. Here we have provided
evidence that such complexes are required for both the
growth and metabolic functions carried out by the Dilps in
Drosophila. Our work suggests an alternative scenario in which
dALS, Imp-L2, and possibly additional Dilp-BPs participate in
an ancestral function used for both metabolism and growth
control.Cell Metabolism 7, 333–338, April 2008 ª2008 Elsevier Inc. 337
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Nomenclature
Gal4 driver lines were named after the gene used for Gal4 expression specific-
ity (for example pumpless, abbreviated ppl), followed by either -Gal4 or > (ppl-
Gal4 or ppl>). The name ppl>dALS is therefore an abbreviation for the geno-
type ppl-Gal4;UAS-dALS, produced by the cross between the ppl-Gal4 line
and the UAS-dALS line.
Fly Stocks
The stocks ppl-Gal4 (ppl>) (Colombani et al., 2003), dilp2-Gal4 (dilp2>) (gift
from E. Rulifson, University of California, San Francisco), UAS-dALS, UAS-
dALSM, UAS-dALSi, UAS-dilp2F, and UAS-SlifA (Colombani et al., 2003)
were used. UAS-SlifA allows reduced expression levels of the Slimfast amino
acid transporter, thereby mimicking a state of amino acid deprivation (Colom-
bani et al., 2003). For each gain- or loss-of-function experiment, a minimum of
two separate lines were used (see Table S2 for details). Adult weight variations
obtained upon dALS gain or loss of function using the ppl-Gal4 driver were
confirmed with an independent fat body driver (cg-Gal4, data not shown).
Animals were reared at 25C (unless otherwise indicated) on fly food contain-
ing, per liter: 17 g inactivated yeast powder, 83 g corn flour, 10 g agar, 60 g
white sugar, 4.6 g nipagin M (in ethanol) (referred to as rich medium, or 13).
0.13 medium contained 1/10 the normal amount of yeast powder.
Plasmid Constructs
pUAS-dALS and pUAS-dALS-myc (pUAS-dALSM) constructs were generated
by cloning an EcoRI/NotI fragment into the pUASt or pUASt-myc vectors (gift
from L. Ruel, CNRS, Nice, France). A dALS cDNA covering the entire predicted
coding region was obtained by fusing a partial dALS cDNA with the 50 missing
sequence amplified by PCR from genomic DNA. The FLAG-dilp2 (UAS-dilp2F)
construct was created by PCR amplifying the dilp2 coding sequence without
the signal peptide sequence from the full-length cDNA clone EST GH11579
(obtained from Research Genetics). The resulting PCR product was then
equipped with the hemagglutinin signal peptide sequence and a FLAG tag
and inserted into pUASt.
The UAS-dALSi construct was generated by cloning a 697 bp fragment of
the dALS cDNA (positions 2018–2715) into the pJM1084 hairpin vector (gift
from J. Montagne, CNRS, Gifs/Yvette, France). The same dALS fragment
was cloned (NheI/BamH1 and XbaI/BglII) in two opposite orientations, allow-
ing the formation of a double-stranded hairpin dALS RNA under UAS control.
Analysis of off-targets related to the dALS hairpin sequence revealed a single
possible off-target on CG11856 with very low gene specificity (0.16%; off-
target size 19 bp). No changes in CG11856 expression were detected upon
UAS-dALSi induction using qPCR.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, two tables, and one figure and can be found with this
article online at http://www.cellmetabolism.org/cgi/content/full/7/4/333/
DC1/.
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